A provision to end pharma's ad tax deductibility was dropped from the One Big Beautiful Bill but still remains firmly in D.C.’s crosshairs.

A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.

Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part of talks with the U.S. government, which is pressuring drugmakers to cut ...

Hyderabad's drug treatment clinic has witnessed an alarming 1300% surge in patient footfall over the past five years, marking the sharpest increase among India's major centers. The clinic, established ...

Hyderabad's drug treatment clinic witnessed a staggering 1300% surge in patient footfall over five years, reaching 9,832 cases by January 2025, the highest spike in India. Primarily treating alcohol, ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s top drug regulator, the agency confirmed Monday.

Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...

Whether Kennedy hands down a ban or one is passed on Capitol Hill, pharma marketing is set to undergo a significant ...

After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...